Complete Filing Data
PROKIDNEY CORP. reported Stockholders Equity of -$1.01 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean PROKIDNEY CORP. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$69.0M | -$61.2M | -$35.5M | -$148.1M | -$55.1M | -$26.7M |
| Operating Income Loss | -$165.0M | -$183.7M | -$151.5M | -$153.0M | -$55.1M | -$27.0M |
| Operating Expenses | $165.9M | $183.8M | $151.5M | $153.0M | $55.1M | $27.0M |
| Research And Development Expense | $114.1M | $127.7M | $106.7M | $82.1M | $46.3M | $21.0M |
| Income Tax Expense Benefit | $414.0K | -$598.0K | $6.0M | $896.0K | $38.0K | -$232.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$151.2M | -$163.9M | -$129.5M | -$147.2M | -$55.1M | -$27.0M |
| General And Administrative Expense | $51.8M | $56.1M | $44.8M | $70.9M | $8.9M | $6.0M |
| Investment Income Nonoperating | $13.8M | $19.8M | $22.1M | $6.0M | $2.0K | $43.0K |
| Interest Expense | $4.0K | $9.0K | $12.0K | $215.0K | $0.00 | $0.00 |
| Net Income Loss Attributable To Redeemable Noncontrolling Interest | -$82.6M | -$102.1M | -$100.0M | -$40.1M | $0.00 | $0.00 |
| Other Comprehensive Income Loss Net Of Tax | -$164.0K | -$200.0K | $497.0K | $0.00 | $0.00 | |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$151.8M | -$163.5M | -$135.0M | -$148.1M | -$55.1M | |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$82.7M | -$102.3M | -$99.6M | -$40.1M | $0.00 | |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -$164.0K | -$200.0K | $497.0K | $0.00 | $0.00 | |
| Comprehensive Income Net Of Tax | -$69.1M | -$61.2M | -$35.3M | -$108.0M | -$55.1M | |
| Accrued Income Taxes Noncurrent | $1.1M | $748.0K | $568.0K | $278.0K | $0.00 | |
| Revenue From Contract With Customer Including Assessed Tax | $893.0K | $76.0K | $0.00 | $0.00 | ||
| Income Taxes Paid Net | $73.0K | $2.9M | $2.0M | $68.0K | $145.0K | |
| Other Asset Impairment Charges | $318.0K | $5.3M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$16.5M | -$16.6M | -$16.7M | -$17.9M | -$12.5M | -$9.5M | -$11.0M | -$9.1M | -$9.7M | -$33.9M | -$2.3M | -$4.0M | -$252.5K | -$143.00 | -$5.2K |
| Operating Income Loss | -$38.5M | -$39.7M | -$41.4M | -$49.0M | -$43.1M | -$40.1M | -$46.6M | -$39.8M | -$40.9M | -$35.6M | -$20.7M | -$66.5M | -$17.1M | -$143.00 | -$5.2K |
| Operating Expenses | $38.8M | $39.9M | $41.6M | $49.0M | $43.1M | $40.1M | $46.6M | $39.8M | $40.9M | $35.6M | $20.7M | $66.5M | $17.1M | $143.00 | $5.2K |
| Research And Development Expense | $26.8M | $25.9M | $27.3M | $31.3M | $29.4M | $27.2M | $32.2M | $26.4M | $25.6M | $21.1M | $11.6M | $28.5M | $14.7M | ||
| Income Tax Expense Benefit | $560.0K | $848.0K | $591.0K | -$2.3M | -$56.0K | $98.0K | $913.0K | $965.0K | $1.3M | -$75.0K | $1.2M | $1.0M | -$60.0K | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$35.3M | -$36.1M | -$37.4M | -$43.4M | -$38.5M | -$35.2M | -$41.1M | -$33.9M | -$35.6M | -$34.0M | -$20.9M | -$66.5M | -$17.1M | ||
| General And Administrative Expense | $11.9M | $14.0M | $14.4M | $17.7M | $13.7M | $12.8M | $14.4M | $13.5M | $15.3M | $14.4M | $9.2M | $38.0M | $2.3M | ||
| Investment Income Nonoperating | $3.3M | $3.6M | $4.0M | $5.6M | $4.5M | $4.8M | $5.5M | $6.0M | $5.3M | $1.6M | $0.00 | $0.00 | $0.00 | ||
| Interest Expense | $2.0K | $1.0K | $0.00 | $2.0K | $3.0K | $2.0K | $2.0K | $4.0K | $3.0K | $29.0K | $170.0K | $14.0K | $1.0K | ||
| Net Income Loss Attributable To Redeemable Noncontrolling Interest | -$19.4M | -$20.4M | -$21.2M | -$23.1M | -$26.0M | -$25.8M | -$31.0M | -$25.7M | $27.2M | $22.0M | $0.00 | $0.00 | $0.00 | ||
| Other Comprehensive Income Loss Net Of Tax | $95.0K | -$100.0K | -$124.0K | $750.0K | $132.0K | -$647.0K | $241.0K | -$413.0K | -$72.0K | $0.00 | $0.00 | $0.00 | |||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$35.7M | -$37.1M | -$38.1M | -$40.3M | -$38.3M | -$36.0M | -$41.8M | -$35.2M | -$37.0M | -$33.9M | -$22.1M | -$67.5M | |||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$19.3M | -$20.5M | -$21.3M | -$22.7M | -$25.9M | -$26.3M | -$30.8M | -$26.0M | -$27.3M | -$22.0M | $0.00 | $0.00 | |||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $95.0K | -$100.0K | -$124.0K | $750.0K | $132.0K | -$647.0K | $241.0K | -$413.0K | -$72.0K | $0.00 | $0.00 | ||||
| Comprehensive Income Net Of Tax | -$16.4M | -$16.6M | -$16.8M | -$17.6M | -$12.5M | -$9.7M | -$10.9M | -$9.2M | -$9.7M | -$11.9M | |||||
| Accrued Income Taxes Noncurrent | $962.0K | $903.0K | $764.0K | $772.0K | $568.0K | $568.0K | $522.0K | $494.0K | $426.0K | $309.0K | |||||
| Revenue From Contract With Customer Including Assessed Tax | $217.0K | $221.0K | $230.0K | $0.00 | $0.00 | $0.00 | |||||||||
| Income Taxes Paid Net | |||||||||||||||
| Other Asset Impairment Charges |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$1.01B | -$995.0M | -$1.10B | -$1.10B | $26.9M | $9.9M | $15.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $108.5M | $99.1M | $60.6M | $490.3M | $20.6M | $4.6M | $15.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $9.4M | $38.5M | -$429.6M | $469.7M | $16.0M | -$10.6M | |
| Retained Earnings Accumulated Deficit | -$1.27B | -$1.20B | -$1.14B | -$1.10B | -$161.5M | ||
| Liabilities Current | $30.7M | $36.2M | $25.0M | $10.9M | $12.3M | ||
| Liabilities And Stockholders Equity | $335.6M | $441.1M | $420.6M | $518.0M | $40.3M | ||
| Finance Lease Principal Payments | $26.0K | $54.0K | $52.0K | $32.0K | $30.0K | $11.0K | |
| Assets Current | $280.7M | $395.9M | $374.1M | $504.7M | $27.3M | ||
| Assets | $335.6M | $441.1M | $420.6M | $518.0M | $40.3M | ||
| Right Of Use Assets Operating And Finance Lease | $3.7M | $3.0M | $4.3M | $2.4M | $1.2M | $1.6M | |
| Operating And Finance Lease Liabilities Current | $1.1M | $765.0K | $803.0K | $493.0K | $267.0K | $1.6M | |
| Property Plant And Equipment Net | $51.2M | $42.2M | $42.1M | $10.7M | $11.4M | ||
| Other Assets Current | $2.8M | $80.0K | $9.0K | $1.4M | $25.0K | ||
| Operating And Finance Lease Liabilities Non Current Portion | $3.0M | $2.5M | $3.6M | $1.9M | $1.1M | ||
| Liabilities | $34.8M | $39.4M | $29.2M | $13.1M | $13.4M | ||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $2.0M | $2.6M | $2.6M | $1.5M | $0.00 | $0.00 | |
| Equipment And Facility Expansion Included In Accounts Payable And Accrued Expenses | $131.0K | $347.0K | $218.0K | $51.0K | $1.3M | $1.8M | |
| Change In Redeemable Noncontrolling Interest For Equity Compensation And Equity Transactions | $3.4M | $19.4M | $2.6M | $5.8M | $0.00 | $0.00 | |
| Cash And Cash Equivalents At Carrying Value | $108.5M | $99.1M | $60.6M | $490.3M | $20.6M | ||
| Accrued Liabilities Current | $28.7M | $31.1M | $17.7M | $7.3M | $9.2M | ||
| Redeemable Noncontrolling Interest Equity Other Carrying Amount | $1.31B | $1.40B | $1.49B | $1.60B | $0.00 | ||
| Accounts Payable Current | $940.0K | $3.6M | $5.1M | $3.0M | $2.8M | ||
| Marketable Securities Unrealized Gain Loss | -$74.0K | $130.0K | |||||
| Gain Loss On Sale Of Property Plant Equipment | -$1.4M | -$56.0K | -$23.0K | $0.00 | $0.00 | ||
| Minority Interest Change In Redemption Value | $0.00 | $0.00 | -$79.0K | $0.00 | |||
| Taxes Payable Current | $0.00 | $682.0K | $1.5M | $0.00 | |||
| Marketable Securities | $161.5M | $259.2M | $302.3M | $0.00 | |||
| Interest Receivable | $1.1M | $2.4M | $1.4M | $0.00 | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $56.0K | $130.0K | $130.0K | $0.00 | |||
| Consolidation Changes Wholly Owned Subsidiary Parent Ownership Interest Changes Impact Of Equity Changes | $448.0K | $14.8M | -$4.8M | ||||
| Net Cash Contribution | $0.00 | $0.00 | $6.1M | $71.5M | $20.0M | ||
| Finite Lived Intangible Assets Net | $0.00 | $213.0K | $428.0K | ||||
| Repayments Of Related Party Debt | $0.00 | $0.00 | $35.0M | $0.00 | $0.00 | ||
| Net Cash From Scs | $0.00 | $0.00 | $108.0K | $0.00 | $0.00 | ||
| Gain Loss On Investments | $3.4M | $7.0M | $6.0M | $0.00 | |||
| Noncontrolling Interest Increase From Subsidiary Equity Issuance | $14.8M | $4.8M | $321.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$1.01B | -$1.00B | -$998.6M | -$979.7M | -$972.4M | -$1.10B | -$1.09B | -$1.32B | -$1.60B | -$1.10B | $6.5M | $20.2M | $10.4M | $15.9M | $19.8K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $95.3M | $84.9M | $97.8M | $108.1M | $214.5M | $84.4M | $191.4M | $243.6M | $271.6M | $506.3M | $21.9M | $29.8M | $4.1M | $223.5K | $0.00 |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$1.3M | $23.7M | -$218.6M | $9.2M | $223.5K | ||||||||||
| Retained Earnings Accumulated Deficit | -$1.25B | -$1.23B | -$1.22B | -$1.18B | -$1.16B | -$1.15B | -$1.13B | -$1.35B | -$1.62B | -$1.10B | -$15.0M | -$12.4M | -$6.3M | -$6.1M | |
| Liabilities Current | $29.1M | $28.3M | $32.8M | $25.2M | $20.6M | $19.3M | $21.0M | $24.5M | $11.3M | $9.8M | $7.9M | $5.4M | $55.1K | $603.1K | |
| Liabilities And Stockholders Equity | $351.6M | $372.1M | $406.1M | $474.8M | $499.2M | $387.8M | $451.8M | $484.2M | $495.2M | $532.4M | $251.0M | $250.8M | $251.4M | $622.8K | |
| Finance Lease Principal Payments | $12.0K | $13.0K | $13.0K | $8.0K | |||||||||||
| Assets Current | $300.0M | $324.4M | $359.7M | $430.2M | $450.3M | $340.2M | $406.4M | $466.4M | $480.1M | $519.4M | $632.3K | $595.0K | $1.4M | $243.1K | |
| Assets | $351.6M | $372.1M | $406.1M | $474.8M | $499.2M | $387.8M | $451.8M | $484.2M | $495.2M | $532.4M | $251.0M | $250.8M | $251.4M | $622.8K | |
| Right Of Use Assets Operating And Finance Lease | $3.9M | $4.2M | $3.1M | $6.0M | $6.3M | $5.7M | $2.7M | $2.9M | $3.0M | $2.1M | |||||
| Operating And Finance Lease Liabilities Current | $991.0K | $903.0K | $857.0K | $1.1M | $1.0M | $1.1M | $676.0K | $654.0K | $624.0K | $426.0K | |||||
| Property Plant And Equipment Net | $47.8M | $43.5M | $43.3M | $38.5M | $42.6M | $41.9M | $42.6M | $14.8M | $11.8M | $10.7M | |||||
| Other Assets Current | $110.0K | $546.0K | $62.0K | $1.0M | $0.00 | $0.00 | $3.0K | $603.0K | $208.0K | $158.0K | |||||
| Operating And Finance Lease Liabilities Non Current Portion | $3.2M | $3.5M | $2.5M | $5.4M | $5.6M | $4.9M | $2.1M | $2.3M | $2.5M | $1.7M | |||||
| Liabilities | $33.3M | $32.7M | $36.1M | $31.3M | $26.8M | $24.7M | $23.6M | $27.3M | $14.2M | $11.9M | $15.6M | $13.1M | $7.8M | ||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $322.0K | $1.7M | $714.0K | $496.0K | |||||||||||
| Equipment And Facility Expansion Included In Accounts Payable And Accrued Expenses | $1.7M | $305.0K | $744.0K | $501.0K | |||||||||||
| Change In Redeemable Noncontrolling Interest For Equity Compensation And Equity Transactions | $4.4M | $7.5M | $1.4M | $0.00 | |||||||||||
| Cash And Cash Equivalents At Carrying Value | $95.3M | $84.9M | $97.8M | $108.1M | $214.5M | $84.4M | $191.4M | $243.6M | $271.6M | $506.3M | $542.3K | $223.5K | |||
| Accrued Liabilities Current | $26.1M | $24.9M | $27.6M | $21.3M | $15.1M | $13.3M | $15.5M | $20.9M | $6.9M | $6.0M | $88.00 | ||||
| Redeemable Noncontrolling Interest Equity Other Carrying Amount | $1.33B | $1.34B | $1.37B | $1.42B | $1.44B | $1.46B | $1.52B | $1.78B | $2.08B | $1.62B | |||||
| Accounts Payable Current | $1.9M | $2.4M | $3.1M | $2.9M | $2.9M | $3.4M | $4.5M | $2.8M | $3.8M | $3.5M | |||||
| Marketable Securities Unrealized Gain Loss | $44.0K | -$45.0K | -$55.0K | $327.0K | $38.0K | -$174.0K | $63.0K | -$108.0K | -$19.0K | ||||||
| Gain Loss On Sale Of Property Plant Equipment | -$300.0K | -$28.0K | -$3.0K | $0.00 | |||||||||||
| Minority Interest Change In Redemption Value | $0.00 | $230.1M | $279.3M | -$509.5M | $176.0K | $0.00 | |||||||||
| Taxes Payable Current | $62.0K | $0.00 | $1.3M | $0.00 | $1.5M | $1.6M | $371.0K | $66.0K | |||||||
| Marketable Securities | $176.4M | $209.8M | $230.7M | $298.7M | $217.0M | $244.6M | $204.9M | $202.6M | $192.0M | ||||||
| Interest Receivable | $1.2M | $1.8M | $1.8M | $5.1M | $2.7M | $1.9M | $714.0K | $8.1M | $5.5M | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $74.0K | $30.0K | $75.0K | $321.0K | -$6.0K | -$44.0K | -$64.0K | -$127.0K | -$19.0K | ||||||
| Consolidation Changes Wholly Owned Subsidiary Parent Ownership Interest Changes Impact Of Equity Changes | $3.0M | -$4.0M | -$5.2M | $766.0K | $22.7M | -$8.7M | -$21.0K | $725.0K | |||||||
| Net Cash Contribution | $0.00 | $5.6M | |||||||||||||
| Finite Lived Intangible Assets Net | $52.0K | $106.0K | $159.0K | $267.0K | |||||||||||
| Repayments Of Related Party Debt | |||||||||||||||
| Net Cash From Scs | |||||||||||||||
| Gain Loss On Investments | $1.1M | $2.3M | |||||||||||||
| Noncontrolling Interest Increase From Subsidiary Equity Issuance | $8.7M | $21.0K | $725.0K | $3.8M | $176.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$120.1M | -$126.4M | -$90.1M | -$77.1M | -$50.3M | -$25.2M |
| Net Cash Provided By Used In Financing Activities | $25.6M | $144.4M | -$9.6M | $548.5M | $71.5M | $20.0M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$5.9M | $11.6M | $11.6M | $494.0K | $7.9M | $683.0K |
| Net Cash Provided By Used In Investing Activities | $104.0M | $20.4M | -$330.0M | -$1.7M | -$5.2M | -$5.5M |
| Share Based Compensation | $25.3M | $29.4M | $30.8M | $74.5M | $699.0K | $730.0K |
| Depreciation Depletion And Amortization | $6.6M | $5.4M | $3.9M | $3.0M | $2.0M | $964.0K |
| Increase Decrease In Accrued Income Taxes Payable | -$356.0K | -$609.0K | $1.8M | $278.0K | $0.00 | $0.00 |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$6.2M | $6.0M | -$4.6M | $7.2M | $5.7M | $809.0K |
| Payments To Acquire Property Plant And Equipment | $15.2M | $29.5M | $34.2M | $1.8M | $5.2M | $5.5M |
| Employee Benefits And Share Based Compensation | $22.4M | $24.5M | $23.8M | $699.0K | ||
| Proceeds From Sale And Maturity Of Marketable Securities | $318.0M | $373.9M | $175.8M | $0.00 | $0.00 | |
| Proceeds From Issuance Of Common Stock | $24.2M | $144.3M | $0.00 | $0.00 | $0.00 | $0.00 |
| Payments To Acquire Marketable Securities | $217.1M | $324.0M | $471.6M | $0.00 | $0.00 | |
| Increase Decrease In Accrued Interest Receivable Net | -$1.3M | $1.1M | $1.4M | $0.00 | ||
| Proceeds From Related Party Debt | $0.00 | $0.00 | $35.0M | $0.00 | $0.00 | |
| Proceeds From Contributed Capital | $6.1M | $71.5M | $20.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$29.6M | -$34.6M | -$26.0M | -$15.5M | -$19.8K | -$138.00 | ||||||||
| Net Cash Provided By Used In Financing Activities | -$12.0K | -$13.0K | -$13.0K | $25.5M | $243.4K | $138.00 | ||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$5.9M | -$5.9M | -$601.0K | $1.5M | $88.00 | $44.00 | ||||||||
| Net Cash Provided By Used In Investing Activities | $28.3M | $58.4M | -$192.6M | -$839.0K | ||||||||||
| Share Based Compensation | $6.4M | $7.7M | $13.0M | $52.7M | ||||||||||
| Depreciation Depletion And Amortization | $1.6M | $1.1M | $832.0K | $710.0K | ||||||||||
| Increase Decrease In Accrued Income Taxes Payable | $591.0K | $98.0K | $148.0K | $957.0K | ||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$5.7M | -$564.0K | -$3.5M | $3.8M | ||||||||||
| Payments To Acquire Property Plant And Equipment | $1.1M | $960.0K | $986.0K | $839.0K | ||||||||||
| Employee Benefits And Share Based Compensation | $5.9M | $5.8M | $5.6M | $6.1M | $6.4M | $6.0M | $10.4M | $8.4M | $10.6M | $8.0M | ||||
| Proceeds From Sale And Maturity Of Marketable Securities | $84.9M | $114.8M | $6.4M | $0.00 | ||||||||||
| Proceeds From Issuance Of Common Stock | ||||||||||||||
| Payments To Acquire Marketable Securities | $55.4M | $55.4M | $198.0M | $0.00 | ||||||||||
| Increase Decrease In Accrued Interest Receivable Net | -$695.0K | $529.0K | $5.5M | $0.00 | ||||||||||
| Proceeds From Related Party Debt | $0.00 | $20.0M | ||||||||||||
| Proceeds From Contributed Capital | $500.0K | $5.6M | $11.5M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2022 |
|---|---|
| Diluted EPS * | -$0.23 |
| Earnings Per Share Basic | $-0.23 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q2 2021 |
|---|---|
| Diluted EPS * | $0.00 |
| Earnings Per Share Basic |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Other Prepaid Expense Current | $2.8M | $4.2M | $3.4M | $2.6M | $588.0K |
| Prepaid Clinical Current | $3.9M | $11.5M | $6.4M | $10.5M | $6.1M |
| Additional Paid In Capital | $258.6M | $205.7M | $36.1M | $7.5M | $0.00 |
| Exchange Of Class B Ordinary Shares Amount | 5.3M | 15.4M | 9.5M | 0.00 | 0.00 |
| Stock Issued During Period Value New Issues | $24.2M | $144.3M | |||
| Exchange Of Class B Ordinary Shares For Class A Ordinary Shares | 5.3M | 15.4M | 9.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Prepaid Expense Current | $3.5M | $2.3M | $3.0M | $6.2M | $3.5M | $3.1M | $4.2M | $4.2M | $5.0M | $3.5M | $524.8K | $543.1K | $897.3K | $19.6K |
| Prepaid Clinical Current | $4.4M | $5.7M | $7.0M | $11.1M | $12.5M | $6.2M | $5.2M | $7.4M | $5.8M | $9.3M | ||||
| Additional Paid In Capital | $242.5M | $231.6M | $218.9M | $199.5M | $189.3M | $53.1M | $41.4M | $31.0M | $21.8M | $1.5M | $24.4K | |||
| Exchange Of Class B Ordinary Shares Amount | 2.4M | 12.6M | 2.3M | 64.0K | 0.00 | |||||||||
| Stock Issued During Period Value New Issues | $7.1M | $4.5M | $139.9M | $6.4M | ||||||||||
| Exchange Of Class B Ordinary Shares For Class A Ordinary Shares | 2.8M | 2.4M | 454.0K | 2.3M | 64.0K |
Most recent annual filing with the SEC: March 18, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.